HSP90AA1 and lymphoma: Taking into account that anti-PD-1 immunotherapy may affect HSP90 expression in NK cells, we assessed the effect of HSP90 downregulation on the degranulation response, granzyme B and IFNγ production in NK cells of lymphoma patients.